Senseonics has filed to obtain CE Mark registration for its one-year continuous glucose monitoring (CGM) system, Eversense 365. The CE Mark submission aligns with the EU Medical Device Regulation (MDR ...

The Food and Drug Administration Feb. 5 released an alert notifying patients of a safety concern using diabetes devices such ...

Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein.

The US FDA warns users of smartphone-linked diabetes devices like CGMs and insulin pumps of potential health risks due to ...

Now that we're a month out from CES, these are the trends that have stuck with me. Yes, AI is on the list, of course, but so ...

Biohacking has moved from niche experiments to a global movement reshaping how we think about human potential. With ...

In today's fast-paced world, maintaining healthy blood sugar levels is crucial for overall well-being. Gluco Control has emerged as a leading solution, helping individuals manage their glucose levels ...

Developed by Northwestern Engineering’s Igor Efimov and George Washington University’s Luyao Lu, the implantable device uses ...

The Health app on your Apple Watch provides a convenient method to consolidate your blood pressure information in one ...

Heart disease is the leading cause of death in the United States, and doctors suggest you might benefit from monitoring your ...

Senseonics announced today that it filed for CE mark for its Eversense 365 continuous glucose monitor (CGM) system.